000756.SZ
新华制药
SZSE · Healthcare · C 制造业 · CN
CNY 13.17
−2.95%Margins
Gross margin
18.6%
EBITDA margin
10.9%
EBIT margin
3.9%
Net margin
3.0%
FCF margin
3.6%
4.9%
Return on equity
2.9%
Return on assets
5.0%
Return on invested capital
0.96x
Asset turnover
CNY 408.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026